precious metals investing Brixton Metals Announces Closing of Option Agreement to Acquire a 100% Interest in the Silver Focused Silvergruvan Project in Sweden
precious metals investing Brixton Metals Reports 97.0% Gold Recovery in Initial Metallurgical Work from the Trapper Gold Target
precious metals investing Brixton Metals Samples New Vein Grading 195 g/t Gold, 4.11% Copper and 147 g/t Silver At Its Thorn Project
precious metals investing Brixton Metals Drills 4 m of 1,975 g/t Silver within 23.50 m of 348 g/t Silver in Hole 449 at its Langis Project in Ontario
precious metals investing Brixton Drills 58 m of 0.50 g/t AuEq and 17.6 m of 1.47 g/t AuEq in the Glenfiddich Zone at Camp Creek, Thorn Project
precious metals investing Brixton Metals Enters into Option Agreement to Acquire a 100% Interest in the Silver Focused Silvergruvan Project in Sweden
precious metals investing Brixton Metals Reports Consistent Silver Grades Across All 85 Holes from Maiden Tailings Drill Program at the Langis Silver Project
precious metals investing Capital Tides 2026 Sets Sail September 10 with 26 Presenting Companies as Final Investor Seats Open
precious metals investing Brixton Metals Drills 6,199 g/t Silver over 1.00 m including 0.50 m of 12,386 g/t Silver in Hole 432 at its Langis Project in Ontario
precious metals investing Brixton Metals Announces Closing Of Final Tranche Of Private Placement For Aggregate Gross Proceeds Of $9.1 Million
precious metals investing Brixton Metals Announces Closing Of Second Tranche Of Its Private Placement
precious metals investing Brixton Metals Announces Non-Brokered Private Placement of up to $5 Million
precious metals investing Brixton Metals Drills 5,015 g/t Silver over 20m in a New Brownfields Discovery Area at Its Langis Project
precious metals investing Brixton Metals Drills 14.75m of 1.25% Copper, 1.71 g/t Gold, 149.0 g/t Silver at the Near Surface Glenfiddich Zone, Camp Creek Corridor
BriaCell Announces ESMO 2026 Poster Highlighting Circulating Immune Biomarker Associated with Clinical Outcomes in Metastatic Breast Cancer
